Programme
Symposium E4
Big data, real world evidence and regulatory science
Wednesday 24 May 2017
09:00-12:00
Stockholmsmässan : A3
Introduction
In recent years, progress in the collection, storage and analysis of real-world data has opened up promising
avenues for pharmaceutical innovation. The challenge for the pharmaceutical sciences will be to harness this
potential and utilize it to explore new treatment strategies and gather valuable evidence on the safety and
effects of medicines in clinical practice. This session will discuss the current state and ways forward.
Co-chairs
Songlin Xue, Astellas, USA
Marieke De Bruin, University of Copenhagen, Denmark
Programme
09:00 – 09:10 Opening remarks
Songlin Xue, Astellas, USA
09:10 – 09:45 Big data as source for pharmaceutical innovation
Arnold Chan, National Taiwan University
09:45-10:20 Opportunities and challenges for Big Data to support regulatory decision making
Alison Cave, European Medicines Agency, UK
10:20 - 10:40 BREAK
10:40 – 11:15 Are there any pre-clinical Big Data?
Beatriz Lima, University of Lisbon, Portugal
11:15 – 12:00 Panel discussion speakers, Q & A and closing remarks
Marieke De Bruin, University of Copenhagen, Denmark
